Program Overview

Diagnostic Radiology

The Department of Diagnostic Radiology offers various programs, including the Radiology Residency, Radiology Fellowships, ABR Alternative Pathway, Imaging Physics Residency, and opportunities for medical students and shadowing in diagnostic imaging.

Subspecialties

The department has several subspecialties, including:

• Body Imaging
• Breast Imaging Section
• Cardiothoracic
• Emergency Imaging
• Molecular Imaging and Therapy
• Musculoskeletal Imaging and Intervention
• Neuroradiology
• Pediatric Radiology

Molecular Imaging and Therapy

Molecular Imaging and Therapy is a section within the Department of Diagnostic Radiology that uses small amounts of radioactive materials to image the function of organs or systems within the body or to treat disease.

Updates

Recent updates include the inaugural virtual Society of Nuclear Medicine and Molecular Imaging (SNMMI) Advanced Theranostics Tumor Board and the opening of the new Molecular Imaging and Therapy clinic in Hatfield Research Center.

Who We Are

The Molecular Imaging and Therapy section uses molecular targeting to deliver radiation preferentially to cells of interest, with limited toxicity to normal organs. The section's clinical mission is to provide advanced, high-quality, safe, and comfortable radionuclide-based imaging and therapy for all patients.

Mission Vision Values

The mission of the Molecular Imaging and Therapy section is to deliver high-quality molecular imaging and therapy services that provide effective, compassionate care and advocacy for patients. The vision is to be global leaders in theranostics, utilizing leading-edge technologies to provide advanced and personalized patient care. The values include positivity, teamwork, integrity, compassion, and wellness.

Residency/ Fellowship

The Nuclear Medicine Residency/Fellowship is an ACGME accredited program that can require 1, 2, or 3 years of commitment. The program offers a well-balanced training encompassing general nuclear medicine, PET imaging, and targeted radioisotope therapies for both adult and pediatric populations.

Candidate Eligibility and Duration of Training

Candidates are expected to satisfy the requirements needed to be eligible for the ABNM certifying examination. The duration of training varies depending on the candidate's background and experience.

Application Information

Applications for the program are accepted through individual applications, not through the National Residency Matching Program (NRMP). A selection committee reviews all application materials.

Routine and Advanced Imaging Services Provided

The section provides various routine and advanced imaging services, including bone scans, hepatobiliary scans, brain scans, and PET imaging.

Therapy

The section performs all FDA-approved radionuclide therapies, including I-131 for hyperthyroidism and thyroid cancer, Y90-ibritumomab for lymphoma, and Lu177-DOTATATE for neuroendocrine tumors.

Theranostics Program

The Theranostics Program combines therapy and diagnostics done with a pair of radiopharmaceuticals. The program enables the development of precision or personalized medicine.

Program Faculty

The program faculty includes:

• Erik S. Mittra, M.D., Ph.D.
• Gagandeep Choudhary, M.D.
• Nadine Mallak, M.D.
• Sebastian Obrzut, M.D.
• Laszlo Szidonya, M.D., Ph.D.
• Kimberly Freitas, D.N.P., NP, AGNP-C

Research

The section is engaged in various research related to Nuclear Medicine, including testing novel radiopharmaceuticals, retrospective studies, and participating in multi-institutional or multi-national prospective studies.

Our History

The Nuclear Medicine section at OHSU began in 1962, and over the years, it has undergone significant developments, including the installation of PET/CT cameras, the start of theranostics programs, and the launch of new therapies.